MoneyWorks4Me

The sales is pegged at Rs. 2410.00 millions for the June 2022 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 2790.00 millions during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -370.00 millions as compared to Net Loss of Rs. -490.00 millions of corresponding quarter ended June 2021Operating profit surged to 540.00 millions from the corresponding previous quarter of 190.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 2410.00 2790.00 -13.62 2410.00 2790.00 -13.62 13720.00 9870.00 39.01
Other Income 490.00 150.00 226.67 490.00 150.00 226.67 380.00 410.00 -7.32
PBIDT 540.00 190.00 184.21 540.00 190.00 184.21 2600.00 -970.00 -368.04
Interest 610.00 550.00 10.91 610.00 550.00 10.91 2730.00 2000.00 36.50
PBDT -70.00 -360.00 -80.56 -70.00 -360.00 -80.56 -130.00 -4390.00 -97.04
Depreciation 470.00 420.00 11.90 470.00 420.00 11.90 1710.00 1840.00 -7.07
PBT -540.00 -780.00 -30.77 -540.00 -780.00 -30.77 -1840.00 -6230.00 -70.47
TAX -170.00 -290.00 -41.38 -170.00 -290.00 -41.38 -440.00 -2310.00 -80.95
Deferred Tax -170.00 -290.00 -41.38 -170.00 -290.00 -41.38 -490.00 -950.00 -48.42
PAT -370.00 -490.00 -24.49 -370.00 -490.00 -24.49 -1400.00 -3920.00 -64.29
Equity 720.00 550.00 30.91 720.00 550.00 30.91 720.00 550.00 30.91
PBIDTM(%) 22.41 6.81 229.02 22.41 6.81 229.02 18.95 -9.83 -292.82
Peers
Company Name CMP
Sun Pharma. Inds. 1792.20
Dr. Reddys Labs. 1198.80
Cipla 1333.45
Lupin 2015.00
Zydus Lifesciences 1145.05
View more..